25 The flavivirus Zika virus (ZIKV) activates ribonuclease L (RNase L) catalytic antiviral 26 function during infection, yet deletion of RNase L decreases ZIKV production, suggesting 27 a proviral role of RNase L. In this study, we reveal that latent RNase L supports ZIKV 28 replication factory (RF) assembly. Deletion of RNase L induced broader cellular 29 distribution of ZIKV dsRNA and NS3 compared with densely concentrated RFs detected 30 in WT cells. An inactive form of RNase L was sufficient to contain ZIKV genome and 31 dsRNA within a smaller area, which increased levels of viral RNA within RFs as well as 32 infectious ZIKV released from the cell. We used a microtubule stabilization drug to 33 demonstrate that RNase L deletion impaired the cytoskeleton rearrangements that are 34 required for proper generation of RFs. During infection with dengue or West Nile Kunjin 35 viruses, RNase L decreased virus production, suggesting that RNase L proviral function 36 is specific to ZIKV. 37 38 39 Keywords 40 Zika virus, flavivirus, RNase L, replication factories, dengue virus, West Nile Kunjin virus 41 42 43 44 45 46 47 3 Introduction 48
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The flavivirus Zika virus (ZIKV) activates ribonuclease L (RNase L) catalytic antiviral 26 function during infection, yet deletion of RNase L decreases ZIKV production, suggesting 27 a proviral role of RNase L. In this study, we reveal that latent RNase L supports ZIKV 28 replication factory (RF) assembly. Deletion of RNase L induced broader cellular 29 distribution of ZIKV dsRNA and NS3 compared with densely concentrated RFs detected 30 in WT cells. An inactive form of RNase L was sufficient to contain ZIKV genome and 31 dsRNA within a smaller area, which increased levels of viral RNA within RFs as well as 32 infectious ZIKV released from the cell. We used a microtubule stabilization drug to 33 demonstrate that RNase L deletion impaired the cytoskeleton rearrangements that are 34 required for proper generation of RFs. During infection with dengue or West Nile Kunjin 35 viruses, RNase L decreased virus production, suggesting that RNase L proviral function 36 is specific to ZIKV. 37 Introduction 7 dependent, and could not detect any RNase L activation by DENV using this assay 139 ( Figure 1B) . Despite reduced RNase L activation by DENV and KUNV, both viruses were 140 restricted by RNase L activity in WT cells ( Figure 1C) . Therefore, RNase L is not only 141 ineffective in inhibiting ZIKV infection, but also specifically promotes ZIKV production 142 (Figure 1A, right panel) . 143 144 RNase L improves ZIKV RF function to increase ZIKV RNA and protein expression. 145
Since infectious virus production was enhanced by RNase L expression, we examined 146 whether RNase L was required for optimal ZIKV replication. We used 147 immunofluorescence assays (IFAs) for detection of the replication intermediate dsRNA 148
and the ZIKV NS3 protein as markers for ZIKV RFs, comparing expression levels in WT 149
and RNase L KO cells. At 20hpi, expression of both ZIKV dsRNA and NS3 was increased 150 in WT cells, as measured by mean dsRNA and NS3 intensity at perinuclear ER sites 151 characteristic of flaviviruses ( Figure 2AB&C) . We also observed a change in localization 152 of ZIKV dsRNA and NS3 in RNase L KO cells, both of which were more disseminated 153 around the nucleus and into the cytoplasm. We used circularity and diameter parameters 154 to quantify the spread of viral products throughout the cell at 20hpi, and determined that 155
RNase L deletion decreased circularity and increased diameter of RFs, distinct from the 156 densely concentrated RF phenotype observed in WT cells (Figure 2AB&C) . We 157 observed this trend of viral RF diffusion in RNase L KO cells as early as 16hpi through 158 30hpi, in two different RNase L KO clones (Figure S1 ). We performed all future analyses 159 on cells fixed at 20hpi, which provides adequate infected cells for quantification purposes, 160 but is early enough for examination of a uniform stage of the viral replication cycle across 161 8 each sample. Additionally, since alterations in ZIKV dsRNA and NS3 were nearly 162 identical, we proceeded to measure effects on RFs using dsRNA expression only. 163
When comparing DENV dsRNA expression and localization in RNase L KO cells 164 to that of WT cells, we found that dsRNA intensity and circularity were decreased while 165 diameter was increased without RNase L, a similar trend but to a lesser degree than with 166 ZIKV (Figure 2D&F) . Furthermore, this does not result in a defect in virus release as 167 measured by viral titer, but instead virus titer is enhanced by RNase L KO (Figure 1C) , 168 suggesting slight changes in RF intensity and shape at the ER do not translate to changes 169 in virus titer during DENV infection. In contrast, KUNV dsRNA intensity increased in 170
RNase L KO cells compared to WT, with little or no change in diameter or circularity of 171 dsRNA, respectively ( Figure 2E&G) . 172
173

Effects of OAS3 knockout on ZIKV RF function. 174
To determine if the involvement of RNase L in ZIKV RF structure requires its nuclease 175 function, we first evaluated ZIKV dsRNA levels and shape of RFs in OAS3 KO cells. As 176 shown in Figure 1 , ZIKV activation of RNase L is dependent on OAS3 expression, 177 therefore deletion of OAS3 eliminates RNase L catalytic activity without affecting RNase 178 L levels (Li et al., 2016) . To confirm RNase L latency in OAS3 KO cells, we measured 2-179 5A, the activator of RNase L synthesized by OAS enzymes, with a fluorescence 180 resonance energy transfer (FRET) assay during ZIKV infection of WT, RNase L KO, and 181 OAS3 KO cells. We detected 2-5A generation during ZIKV infection of both WT and 182
RNase L KO cells, however 2-5A in ZIKV-infected OAS3 KO cells was not increased over 183 levels in mock infected WT cells ( Figure 3A) . This confirmed previous results indicating 184 9 that OAS3 is the primary human OAS isoform required for 2-5A synthesis during viral 185 infections (Li et al., 2016 , Whelan et al., 2019 , and verified that other OAS isoforms did 186 not compensate for loss of OAS3 expression during ZIKV infections. Together these 187 results suggest that OAS3 is the primary producer of 2-5A during ZIKV infection, thereby 188 providing a useful system for investigating RNase L function independent of its catalytic 189 activity during viral infection. 190
We next used IFAs to compare dsRNA expression levels and localization in ZIKV 191 infected OAS3 KO cells to that of infected WT and RNase L KO cells. We used protein 192 disulfide isomerase (PDI) as a marker for the ER, where RFs reside. At 20hpi, ZIKV 193 dsRNA intensity in the OAS3 KO cells was rescued to WT levels from that of RNase L 194 KO cells ( Figure 3B&C ). Furthermore, RFs in OAS3 KO cells were more circular and 195 smaller in diameter than in both RNase L KO and WT cells, suggesting additional RF 196 support from inactive RNase L compared to in WT cells ( Figure 3B&C) . While some 197 changes in DENV and KUNV dsRNA expression in OAS3 KO cells displayed a similar 198 trend as that of ZIKV dsRNA, changes were minimal in comparison with alterations in 199 ZIKV dsRNA observed in OAS3 KO cells ( Figure S2) . 200 We also found that by 48hpi OAS3 KO, which suppresses RNase L activation, 201 restored infectious ZIKV production from reduced levels of RNase L KO cells to that 202 observed during WT cell infection ( Figure 3D) . DENV production, which was limited by 203
RNase L in WT cells, was not improved by OAS3 KO, suggesting an OAS3-independent 204
RNase L-mediated inhibition of DENV infection (Figure 3D ). While KUNV production was 205 also limited by RNase L in WT cells, it improved with OAS3 KO as observed with ZIKV. 206
However, unlike DENV, KUNV activation of RNase L was OAS3-dependent ( Figure 1B) . 207 Therefore, increased KUNV yields from OAS3 KO cells were likely due to the lack of 208
RNase L mediated antiviral activity ( Figure 3D) . These results from cells lacking OAS3 209 suggest that ZIKV infection may utilize an inactive form of RNase L in a unique manner 210 that results in higher virus production than with RNase L absent. revealed that deletion of RNase L did not alter intensity of genome expression when 230 compared to WT cells. Since genome staining was not circular in shape, we instead used 231 total area to measure increased dissemination of genome throughout the infected cell 232 without RNase L ( Figure 4D ). Inactive RNase L in OAS3 KO cells restored the area of 233 genome expression from that of RNase L KO cells back to the area measured in WT cells 234 ( Figure 4D ). Furthermore, genome confined to RFs in OAS3 KO cells resulted in higher 235 levels of genome compared to WT and RNase L KO cells (Figure 4D ), suggesting that 236 genome location within the cell dictates new virus release ( Figure 3D ). Enhanced genome 237 intensity in OAS3 KO cells over that of WT cells is possibly due to inactive RNase L 238 availability for RF support, as opposed to in WT cells wherein RNase L is activated and 239 performs other functions, namely degrading RNA. 240
In contrast to ZIKV, DENV and KUNV genome staining and cellular localization 241 was similar in WT, RNase L KO, and OAS3 KO cells, with genome residing at the ER 242 regardless of RNase L presence or activation status ( Figure 4B&C ). Quantification of 243 DENV total genome staining determined that RNase L deletion increased the area and 244 intensity of genome expression over that in cells lacking OAS3-dependent RNase L 245 activity ( Figure 4E ), suggesting OAS3-independent antiviral effects of RNase L on DENV 246 new genome synthesis, which correlates with increased DENV titers in RNase L KO cells 247 but not OAS3 KO cells ( Figure 3D ). Quantification of KUNV genome staining exhibited 248 only minor alterations in intensity, with genome in OAS3 KO cells only increased over that 249
in RNase L KO cells, but not increased over that in WT cells as was observed for ZIKV 250 ( Figure 4F ). Since KUNV does not activate RNase L until 48hpi by rRNA degradation 251 assay ( Figure 1B ), we had not expected a change in genome intensity between cell lines 252 at 20hpi. Additionally, the area of KUNV genome expression was increased in RNase L 253 KO cells compared to both WT and OAS3 KO cells, but to a lesser degree than during 254 ZIKV infection ( Figure 4F) . Overall, absence of OAS3-dependent RNase L activity had a 255 greater impact on ZIKV genome localization and expression compared to that of DENV 256 and KUNV, which agrees with its minimal effects on DENV and KUNV RFs and viral titers. 257 258 ZIKV RFs are unaffected by pIC treatment in the absence of OAS3. 259
The lack of rRNA degradation ( Figure 1B ) and 2-5A production ( Figure 3A induced by pIC ( Figure 5B) . In OAS3 KO cells, pIC transfection before ZIKV infection 279 had no effect on dsRNA expression, further demonstrating that RNase L was not 280 activated in the absence of OAS3 (Figure 5C) . 281
To corroborate these results with a more quantitative method, we also used this 282 system to demonstrate that pIC treatment before ZIKV infection of OAS3 KO cells had no 283 effect on infectious ZIKV production. After transfecting cells for 2h with pIC, cells were 284 infected with ZIKV for 24hpi, and viral titers were measured by plaque assay. Without 285 pIC, ZIKV titers in all three cell lines were similar at 24hpi, which agrees with previous 286
data showing decreased ZIKV from RNase L KO cells only after 24hpi ( Figure 5D ). In 287 WT cells with pIC-induced activation of RNase L, infectious ZIKV production was 288 restricted. In RNase L KO and OAS3 KO cells, pIC only slightly inhibited ZIKV production, 289
indicating that restriction of viral titers in WT cells was predominantly due to RNase L 290 antiviral activity ( Figure 5D ). These results correlate with absence of dsRNA detection in 291 only WT cells after pIC transfection ( Figure 5C ), and establish that RNase L is not 292 catalytically active in OAS3 KO cells. This also maintains that decreased ZIKV in RNase 293 L KO cells compared to WT and OAS3 KO cells ( Figure 3D ) is not due to RNase L-294 independent antiviral responses that subsequently limit virus production, as responses 295 unrelated to RNase L induced by pIC in RNase L KO or OAS3 KO cells had only a minor 296 effect on titers ( Figure 5D ). Finally, these results suggest that inactive RNase L retains 297 ZIKV genome in smaller, more efficient RFs. We next directly investigated whether an inactive form of RNase L can enhance 302 ZIKV RF function to augment infectious virus production using a different cell line. To 303 complement our A549 model, in which RNase L pathway components were deleted, we 304
infected HeLa M cells stably expressing either RNase L WT (+RL WT) or RNase L 305 nuclease dead mutant R667A (+RL R667A) (Dong et al., 2001) . We also infected HeLa 306 M cells expressing the empty pcDNA3 vector (vector control, VC) that have undetectable 307 levels of RNase L protein by western blotting (Figure 6A ). This provided an RNase L-308 deficient cell line as a control for this system, in addition to verification that effects in RL 309
R667A-expressing cells were not possibly due to endogenous RNase L WT expression. 310
While RL WT protein expression was lower than that of RL R667A, it was sufficient for 311
RNase L-mediated rRNA degradation, which was only detectable in ZIKV infected +RL 312 WT cells and not VC or +RL R667A cells, despite OAS3 protein expression in all three 313 cell lines ( Figure 6A&B) . We evaluated effects of RNase L WT or R667A expression on 314 ZIKV dsRNA expression and localization compared to that of VC cells at 20hpi, using PDI 315 ER staining to denote RF sites. We found that expression of either RL WT or RL R667A 316 increased ZIKV dsRNA intensity at the ER over that in VC cells, however only RL R667A 317 increased circularity of ZIKV RFs in comparison to those of VC cells (Figure 6C&D) . To 318 determine if RNase L effects on ZIKV dsRNA intensity or circularity correlated with 319 elevated infectious ZIKV titers, we measured virus from infected HeLa M cells at 48hpi 320 and detected a significant increase in ZIKV production in RL R667A-expressing cells 321 compared to VC or RL WT-expressing cells (Figure 6E) . In addition, we found that neither 322 RL WT nor RL R667A expression increased DENV or KUNV titers, demonstrating a 323 proviral effect of catalytically inactive RNase L on ZIKV in particular ( Figure 6E) . 324 Furthermore, expression of RL WT, but not RL R667A, slightly decreased KUNV 325 production at 48hpi ( Figure 6E) Figure 7C) . We validated effects of paclitaxel treatment on microtubule stability by 359 staining btubulin, which together with atubulin makes up microtubules. In ZIKV infected 360 WT cells, btubulin localized to dsRNA staining, which agrees with previous findings of 361 ZIKV-induced microtubule rearrangements surrounding RFs (Figure 7D) (Cortese et al., 362 2017) . In RNase L KO cells, btubulin was no longer detectable at concentrated RFs, 363 similar to dissemination of ZIKV dsRNA or NS3 without RNase L expressed (Figure 7D) . 364
Paclitaxel treatment of both ZIKV infected WT and RNase L KO cells resulted in btubulin 365
aggregation due to inhibition of microtubule tractability (Figure 7E) . Finally, we treated 366 cells with paclitaxel 3h after infecting with ZIKV to measure changes in infectious virus 367 production at 24hpi as a result of microtubule stabilization in WT and RNase L KO cells. 368
Paclitaxel in WT cells reduced infectious ZIKV titers to the level of RNase L KO cells 369 ( Figure 7F) . Moreover, paclitaxel did not reduce ZIKV titers in RNase L KO cells, 370
suggesting that the paclitaxel means of blocking ZIKV production was lost in RNase L KO 371 cells where microtubule associations with ZIKV RFs were already weak due to absence 372 of RNase L (Figure 7F) . Together with the effects of paclitaxel on dsRNA expression, 373 these results offer a mechanism for RNase L-mediated increased ZIKV production 374 through ZIKV employment of RNase L-cytoskeleton interactions during formation of RFs. 375 376
Discussion 377
In this study, we present findings supporting a proviral role of the host RNase L protein, 378 which has otherwise been considered strictly antiviral. RNase L nucleolytic activity is 379 highly effective at restricting replication of a diverse range of DNA and RNA viruses 380 (Silverman, 2007) . However, catalytic activation of RNase L by ZIKV does not limit 381 infection, and instead ZIKV titers are paradoxically increased with RNase L expression. 382
In particular, a catalytically inactive form of RNase L improved ZIKV RF assembly and 383 function, thereby boosting virus production. We also provide evidence suggesting that 384 ZIKV repurposes the interaction between RNase L and the cytoskeleton to facilitate 385 rearrangement of the ER for establishment of ZIKV RFs. While cytoskeletal arrangements 386 for RF assembly within ER folds are characteristic of flaviviruses, we found that RNase L 387 expression during DENV and KUNV infection had only minimal effects on RF formation. 388 Furthermore, RNase L was ultimately restrictive of both viruses, operating in its canonical 389 antiviral manner to decrease DENV and KUNV titers through its catalytic activity. 390
Therefore, we propose that recruitment of RNase L for enhanced RF function and virus 391 release is a feature presently observed only during ZIKV infection. 392
Interestingly, DENV production in WT cells was limited by RNase L, as titers 393 increased significantly in RNase L KO cells ( Figure 1C ), although we were unable to 394 detect any rRNA degradation in DENV-infected WT cells ( Figure 1B) . Unlike other viruses 395 we have examined, RNase L antiviral effects on DENV were not dependent on OAS3, as 396 viral titers in WT and OAS3 KO cells were similar ( Figure 3D ). Moreover, RNase L deletion 397 enhanced DENV genome expression ( Figure 4B&E ), which correlates with increased 398 titers in RNase L KO cells, and suggests that RNase L is activated during DENV infection. 
ZIKV infection (Figures 3&4). 414
To validate our results in A549 cells, we used HeLa M cells stably expressing 415
RNase L WT, an RNase L catalytic mutant R667A, or an empty vector. Since HeLa M 416 cells do not express endogenous RNase L, the empty vector-expressing cells served as 417 an RNase L-deficient control for these experiments. In addition, HeLa M cells were 418 permissive to flavivirus infection and therefore offered a convenient system for isolation 419 of RNase L catalytic and non-catalytic functions during infection. However, one caveat 420
we encountered was the variance in RNase L WT and R667A protein levels, which 421 occurred when overexpressing these constructs in several cell types. RNase L activation 422 induces apoptosis to limit viral infection, therefore it was important to eliminate the 423 possibility of spontaneous activation of RNase L and subsequent induction of apoptosis 424 in cells stably expressing RNase L WT, which would reduce cell quantity. We verified that 425
RNase L was not activated in uninfected HeLa M cells expressing RNase L WT, as we 426 did not detect any rRNA degradation in mock infected cells ( Figure 6B, 3 
rd column). 427
Moreover, levels of RNase L WT in HeLa M cells were sufficient for rRNA degradation 428 ( Figure 6B ) and slightly reduced KUNV production ( Figure 6E 
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The authors declare no competing interests. Australia (Khromykh and Westaway, 1994) , and propagated in BHK-21 cells. 605
Virus replication assays 606
Cells were seeded into 24-well plates and infected the next day at indicated MOI in 607 triplicate. After 1h incubation of cells with virus at 37°C, virus was removed and cells 608 washed three times with PBS before addition of 1mL complete media. At indicated time 609 post-infection, 150µl supernatants were harvested and stored at -80°C until titration, and 610 150µl complete media replaced in each well so that all time points from one replicate 611 contain supernatant from the same infected well throughout the time course. Data is 612
representative of 2 or more experiments. 613
Plaque assays 614
Virus supernatant from infected cells was serially diluted in DMEM supplemented with 2% 615 FBS and added to Vero cell monolayers in 6-well plates. Plates were incubated for 1 hour 616 at 37°C before overlaying infected monolayers with DMEM containing 3% FBS, 8% 617 NaCO3, 10mM HEPES, 1X L-glutamine, 250µg/mL amphotericin B, and 0.7% agarose. 618 glass slides and sealed using ProLong Gold antifade reagent (Invitrogen P36930), and 642 imaged using a Nikon Ti2E fluorescence widefield microscope at 60X ( Figure 5 ) or 100X 643 magnification ( Figure S1 ), or using a VT-iSIM confocal microscope at 100X magnification 644 (all other IFA images). Images shown are representative of 5 or more fields of view taken 645 per condition, for each of 2 or more independent experiments. All images within individual 646 experiments were batch processed using the same contrast and threshold settings before 647 measurement. IFAs for quantification were imaged on a Nikon Ti2E fluorescence 648 widefield microscope at 20X magnification. 649
Fluorescence in situ hybridization 650 A549 cells were seeded onto 8-well chamber slides (EMD Millipore) and the next day 651 infected with ZIKV at an MOI of 1. At 20hpi, cells were fixed with 10% formalin for 30 652 minutes at RT, dehydrated, rehydrated, treated with protease and stained with fluorescent 653 labels specific to positive-strand ZIKV genome (cat 521511), positive-strand DENV 654 genome (cat 528001), or positive-strand West Nile virus genome (cat 475091) using 655
RNAscope® Fluorescent Multiplex Reagent Kit (Advanced Cell Diagnostics, Inc.). After 656 FISH staining, slides were rinsed with ddH2O, rinsed with PBS, then blocked with BSA 657 and stained for PDI as described for IFAs, using goat anti-rabbit Alexa fluor Ò 488 658 (Invitrogen A11005) secondary antibody for green ER staining. RNA was imaged on a 659 VT-iSIM confocal microscope at 100X magnification. Images shown are representative of 660 5 or more fields of view taken per condition, for each of 2 or more independent 661 experiments. All images within individual experiments were batch processed using the 662 same contrast and threshold settings before measurement. Images for quantification 663 were taken on a Nikon Ti2E fluorescence widefield microscope at 20X magnification. 664
